Locally Advanced Resectable Head and Neck Squamous Cell Carcinoma: A Prospective, Single-Arm Clinical Study

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
This is a prospective, single-arm, phase II study. It aims to evaluate whether neoadjuvant targeted therapy combined with immunotherapy and chemotherapy is effective and safe in patients with locally advanced, resectable head and neck squamous cell carcinoma (HNSCC).
Epistemonikos ID: 68544ca6c7b7d5da3017cbb797a8aaa0b002aba7
First added on: Oct 31, 2026